Cargando…

Vimentin-Positive Circulating Tumor Cells as Diagnostic and Prognostic Biomarkers in Patients with Biliary Tract Cancer

Biliary tract cancer (BTC) has poor prognosis; thus, early diagnosis is important to decrease mortality. Although vimentin-positive circulating tumor cells (V-CTCs) are a good candidate for diagnostic and prognostic biomarkers, studies on the topic are limited. We aimed to evaluate the diagnostic ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Sung Yong, Park, Sung Hee, Ko, Hyun Suk, Jang, Aelee, Seo, Hyung Il, Lee, So Jeong, Kim, Gwang Ha, Kim, Dong Uk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509386/ https://www.ncbi.nlm.nih.gov/pubmed/34640452 http://dx.doi.org/10.3390/jcm10194435

Ejemplares similares

Circulating Tumor Cell Clusters Are Cloaked with Platelets and Correlate with Poor Prognosis in Unresectable Pancreatic Cancer
por: Lim, Minji, et al.
Publicado: (2021)

Liquid Biopsy from Bile-Circulating Tumor DNA in Patients with Biliary Tract Cancer
por: Han, Jin-Yi, et al.
Publicado: (2021)

Diagnostic Role of Bile Pigment Components in Biliary Tract Cancer
por: Ahn, Keun Soo, et al.
Publicado: (2023)

Development and validation of circulating protein signatures as diagnostic biomarkers for biliary tract cancer
por: Christensen, Troels D., et al.
Publicado: (2022)

Complementary and Alternative Medicine Use and Its Association with Emotional Status and Quality of Life in Patients with a Solid Tumor: A Cross-Sectional Study
por: Jang, Aelee, et al.
Publicado: (2017)

Genomic Alterations in Biliary Tract Cancer Using Targeted Sequencing()
por: Yoo, Kwai Han, et al.
Publicado: (2016)

Prognostic Factors in Patients Treated with Pembrolizumab as a Second-Line Treatment for Advanced Biliary Tract Cancer
por: Park, Chan Su, et al.
Publicado: (2022)

Risk Factors for Early- and Late-Onset Cholecystitis after Y-Configured Metal Stent Placement in Patients with Malignant Hilar Biliary Obstruction: A Single-Center Study
por: Lee, Jonghyun, et al.
Publicado: (2023)

Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers
por: Letelier, Pablo, et al.
Publicado: (2016)

Diagnostic performance of contrast enhanced CT and (18)F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection
por: Lee, Yun-Gyoo, et al.
Publicado: (2011)

Prognostic Significance of Sarcopenia in Advanced Biliary Tract Cancer Patients
por: Lee, Byung min, et al.
Publicado: (2020)

Safety Evaluation of Paclitaxel-Eluting Biliary Metal Stent with Sodium Caprate in Porcine Biliary Tract
por: Jang, Sung Ill, et al.
Publicado: (2019)

Prognostic value of Dickkopf-1 and ß-catenin expression according to the antitumor immunity of CD8-positive tumor-infiltrating lymphocytes in biliary tract cancer
por: Kim, Seo Ree, et al.
Publicado: (2022)

EUS-guided biliary drainage versus ERCP for first-line palliation of malignant distal biliary obstruction: A systematic review and meta-analysis
por: Han, Sung Yong, et al.
Publicado: (2019)

Preventive effect of biodegradable stents on biliary stricture and fibrosis after biliary anastomosis in a porcine model
por: Kwon, Chang-Il, et al.
Publicado: (2022)

HER2 Aberrations as a Novel Marker in Advanced Biliary Tract Cancer
por: Kim, Hongsik, et al.
Publicado: (2022)

RRM1 Expression as a Prognostic Biomarker for Unresectable or Recurrent Biliary Tract Cancer Treated with Gemcitabine plus Cisplatin
por: Chun, Jung Won, et al.
Publicado: (2021)

Pronounced squamous cell contamination in biliary tract cytology: A diagnostic pitfall
por: Tomm, Nicole K., et al.
Publicado: (2022)

Prognostic Factors and Scoring Model for Survival in Metastatic Biliary Tract Cancer
por: Park, Hyung Soon, et al.
Publicado: (2017)

Expression Profiles of Circulating MicroRNAs in XELOX-Chemotherapy-Induced Peripheral Neuropathy in Patients with Advanced Gastric Cancer
por: Ju, Yeongdon, et al.
Publicado: (2022)

Evaluation of Cell Surface Vimentin Positive Circulating Tumor Cells as a Diagnostic Biomarker for Lung Cancer
por: Xie, Xiaohong, et al.
Publicado: (2021)

Does the pancreatic volume reduction rate using serial computed tomographic volumetry predict new onset diabetes after pancreaticoduodenectomy?
por: Yun, Sung Pil, et al.
Publicado: (2017)

Diagnostic challenges of nonodontogenic toothache
por: Park, Hyung-Ok, et al.
Publicado: (2012)

MicroRNA 141 Expression Is a Potential Prognostic Marker of Biliary Tract Cancers
por: Kim, Jaihwan, et al.
Publicado: (2016)

Role of endoscopic biliary drainage in advanced hepatocellular carcinoma with jaundice
por: Woo, Hyun Young, et al.
Publicado: (2017)

Establishing Patient-Derived Cancer Cell Cultures and Xenografts in Biliary Tract Cancer
por: Kang, Jihoon, et al.
Publicado: (2023)

Predictive Factors of Biliary Tract Cancer in Anomalous Union of the Pancreaticobiliary Duct
por: Park, Jin-Seok, et al.
Publicado: (2016)

Postprandial Hypotension as a Risk Factor for the Development of New Cardiovascular Disease: A Prospective Cohort Study with 36 Month Follow-Up in Community-Dwelling Elderly People
por: Jang, Aelee
Publicado: (2020)

Overexpressions of Vimentin and Integrins in Human Metastatic Spine Tumors
por: Park, Sung Bae, et al.
Publicado: (2015)

The efficacy of immune checkpoint inhibitors in biliary tract cancer with KRAS mutation
por: Jeong, Sun Young, et al.
Publicado: (2023)

Efficacy of a Newly Developed Guidewire for Selective Biliary Cannulation: A Multicenter Randomized Controlled Trial
por: Han, Sung Yong, et al.
Publicado: (2023)

Expression of Vimentin Intermediate Filament for Vascular Development in Olive Flounder (Paralichthys olivaceus)
por: Yang, Hyun, et al.
Publicado: (2014)

Vimentin and Anti Vimentin Antibodies in Chagas' Disease
por: Nascimento, Marilda Savoia, et al.
Publicado: (2018)

Clinical impact of bile‐derived exosomal microRNAs as novel diagnostic and prognostic biomarkers for biliary tract cancers
por: Yoshida, Michihiro, et al.
Publicado: (2022)

Tumor microenvironment-derived serum markers as a new frontier of diagnostic and prognostic assessment in biliary tract cancers
por: Désert, Romain, et al.
Publicado: (2023)

Tumor Mutational Burden as a Biomarker for Advanced Biliary Tract Cancer
por: Kim, Hongsik, et al.
Publicado: (2021)

Physical Activity and Gastric Cancer Risk in Patients with and without Helicobacter pylori Infection in A Korean Population: A Hospital-Based Case-Control Study
por: Gunathilake, Madhawa Neranjan, et al.
Publicado: (2018)

Spatial Distribution and Prognostic Implications of Tumor-Infiltrating FoxP3(−) CD4(+) T Cells in Biliary Tract Cancer
por: Kim, Hyung-Don, et al.
Publicado: (2021)

Chemotherapy versus Best Supportive Care in Advanced Biliary Tract Carcinoma: A Multi-institutional Propensity Score Matching Analysis
por: Ji, Jun Ho, et al.
Publicado: (2018)

Intraductal papillary mucinous neoplasm of the biliary tract with cardiac metastasis: A case report
por: Lee, Joo Hyung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3788bh0a622k07l736ssh2j6ub